A Weintraub

Author PubWeight™ 91.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Enteropathogens in adult patients with diarrhea and healthy control subjects: a 1-year prospective study in a Swedish clinic for infectious diseases. Clin Infect Dis 2000 2.77
2 Crystal structure of phage P22 tailspike protein complexed with Salmonella sp. O-antigen receptors. Proc Natl Acad Sci U S A 1996 1.66
3 Phage P22 tailspike protein: crystal structure of the head-binding domain at 2.3 A, fully refined structure of the endorhamnosidase at 1.56 A resolution, and the molecular basis of O-antigen recognition and cleavage. J Mol Biol 1997 1.55
4 Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts. J Bacteriol 1996 1.47
5 Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization. J Bacteriol 1983 1.40
6 Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm. Clin Microbiol Infect 2009 1.31
7 Immunochemical identification of Brucella abortus lipopolysaccharide epitopes. Clin Diagn Lab Immunol 1994 1.31
8 The lipopolysaccharide of Shigella bacteria as a virulence factor. Rev Infect Dis 1991 1.29
9 Prevalence of enterotoxigenic Bacteroides fragilis in adult patients with diarrhea and healthy controls. Clin Infect Dis 1999 1.27
10 Interactions of phage P22 tails with their cellular receptor, Salmonella O-antigen polysaccharide. Biophys J 1996 1.26
11 The role of Bacteroides fragilis in the pathogenesis of acute appendicitis. Acta Chir Scand 1982 1.25
12 Nature, type of linkage, quantity, and absolute configuration of (3-hydroxy) fatty acids in lipopolysaccharides from Bacteroides fragilis NCTC 9343 and related strains. J Bacteriol 1980 1.21
13 Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238). Carbohydr Res 1994 1.14
14 Intracardiac, intravascular, two-dimensional, high-frequency ultrasound imaging of pulmonary artery and its branches in humans and animals. Circulation 1990 1.12
15 Gastroesophageal reflux during gastrostomy feeding. Gastroenterology 1994 1.12
16 Structure of the capsular polysaccharide of Vibrio cholerae O139 synonym Bengal containing D-galactose 4,6-cyclophosphate. Eur J Biochem 1995 1.11
17 Three-dimensional and four-dimensional transesophageal echocardiographic imaging of the heart and aorta in humans using a computed tomographic imaging probe. Echocardiography 1992 1.11
18 Rapid detection of Vibrio cholerae O139 Bengal from stool specimens by PCR. J Clin Microbiol 1997 1.10
19 The outer membrane of Brucella ovis shows increased permeability to hydrophobic probes and is more susceptible to cationic peptides than are the outer membranes of mutant rough Brucella abortus strains. Infect Immun 1999 1.09
20 Plasmid-mediated quinolone resistance determinant qnrS in Enterobacter cloacae. Clin Microbiol Infect 2006 1.08
21 Phage specific for Vibrio cholerae O139 Bengal. J Clin Microbiol 1996 1.08
22 Chemical and immunochemical analyses of Bacteroides fragilis lipopolysaccharides. Infect Immun 1985 1.05
23 Structural studies on the short-chain lipopolysaccharide of Vibrio cholerae O139 Bengal. Eur J Biochem 1997 1.01
24 Enzymatic synthesis and isolation of thymidine diphosphate-6-deoxy-D-xylo-4-hexulose and thymidine diphosphate-L-rhamnose. Production using cloned gene products and separation by HPLC. Eur J Biochem 1992 1.01
25 Heterogeneity of Brucella abortus lipopolysaccharides. Res Microbiol 1995 1.01
26 Structural studies of the O-antigenic polysaccharide from Escherichia coli O139. Eur J Biochem 1998 1.01
27 Human endothelial cell adhesiveness for neutrophils, induced by Escherichia coli lipopolysaccharide in vitro, is inhibited by Bacteroides fragilis lipopolysaccharide. J Immunol 1989 1.00
28 Cloning and sequence of a region of Vibrio cholerae O139 Bengal and its use in PCR-based detection. J Clin Microbiol 1996 0.98
29 Multiplane transesophageal echocardiography. Imaging planes, echocardiographic anatomy, and clinical experience with a prototype phased array OmniPlane probe. Echocardiography 1992 0.97
30 Identification of Bacteroides fragilis by indirect immunofluorescence. Med Microbiol Immunol 1979 0.97
31 A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism. J Pediatr 2001 0.97
32 Expression of the Shigella dysenteriae type-1 lipopolysaccharide repeating unit in Escherichia coli K12/Shigella dysenteriae type-1 hybrids. Eur J Biochem 1993 0.96
33 Pacemaker lead infection and vertebral osteomyelitis presumed due to Cardiobacterium hominis. Clin Infect Dis 1998 0.96
34 Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis. Rev Infect Dis 1990 0.96
35 Treatment of enterotoxigenic and enteropathogenic Escherichia coli-induced diarrhoea in children with bovine immunoglobulin milk concentrate from hyperimmunized cows: a double-blind, placebo-controlled, clinical trial. Scand J Gastroenterol 2000 0.96
36 Interaction of Salmonella phage P22 with its O-antigen receptor studied by X-ray crystallography. Biol Chem 1997 0.94
37 Characterization of Bacteroides fragilis strains based on antigen-specific immunofluorescence. J Infect Dis 1983 0.94
38 Antibody response and protection against challenge in mice vaccinated intraperitoneally with a live aroA O4-O9 hybrid Salmonella dublin strain. Infect Immun 1993 0.92
39 Encapsulated strains of Bacteroides fragilis in clinical specimens. Med Microbiol Immunol 1979 0.92
40 Structural studies of the polysaccharide part of the cell wall lipopolysaccharide from Bacteroides fragilis NCTC 9343. Eur J Biochem 1985 0.92
41 Virulence factors in infections with bacteroides fragilis: isolation and characterization of capsular polysaccharide and lipopolysaccharide. Scand J Infect Dis Suppl 1982 0.91
42 The humoral antibody response to Bacteroides fragilis infections in humans. Scand J Infect Dis Suppl 1979 0.91
43 Structural studies of the Escherichia coli O26 O-antigen polysaccharide. Carbohydr Res 1996 0.89
44 Enthalpic barriers to the hydrophobic binding of oligosaccharides to phage P22 tailspike protein. Biochemistry 2001 0.89
45 Monoclonal antibodies to Bacteroides fragilis lipopolysaccharide. J Clin Microbiol 1984 0.88
46 Construction of Salmonella strains with both antigen O4 (of group B) and antigen O9 (of group D). J Bacteriol 1992 0.87
47 Rapid and sensitive assay for detection of enterotoxigenic Bacteroides fragilis. J Clin Microbiol 1998 0.87
48 Mutations improving the folding of phage P22 tailspike protein affect its receptor binding activity. J Mol Biol 1999 0.86
49 Intracardiac echocardiographic imaging of cardiac abnormalities, ischemic myocardial dysfunction, and myocardial perfusion: studies with a 10 MHz ultrasound catheter. J Am Soc Echocardiogr 1993 0.85
50 Phagocytosis of Vibrio cholerae O139 Bengal by human polymorphonuclear leukocytes. Clin Diagn Lab Immunol 1999 0.85
51 Real-time intravascular ultrasound imaging in humans. Am J Cardiol 1990 0.85
52 Real-time intracardiac two-dimensional echocardiography: an experimental study of in vivo feasibility, imaging planes, and echocardiographic anatomy. Echocardiography 1990 0.84
53 Antibiotic resistance patterns of Escherichia coli isolates from different aquatic environmental sources in León, Nicaragua. Clin Microbiol Infect 2012 0.84
54 The beta-configuration of the rhamnosidic linkage in Salmonella serogroups C2 and C3 lipopolysaccharide is important for the immunochemistry of the O-antigen 8. Mol Immunol 1993 0.82
55 Once daily cefixime compared with twice daily trimethoprim/sulfamethoxazole for treatment of urinary tract infection in infants and children. Pediatr Infect Dis J 1992 0.82
56 Abdominal aortic aneurysms. Clinical status and results of surgery in 100 consecutive cases. JAMA 1967 0.82
57 New perspectives on neonatal hyperbilirubinemia. Mt Sinai J Med 1994 0.82
58 Structural determination and biosynthetic studies of the O-antigenic polysaccharide from the enterohemorrhagic Escherichia coli O91 using 13C-enrichment and NMR spectroscopy. Biochemistry 1999 0.82
59 Depolymerization of the capsular polysaccharide from Vibrio cholerae O139 by a lyase associated with the bacteriophage JA1. Carbohydr Res 2001 0.81
60 Structural studies of the Escherichia coli O90 O-antigen polysaccharide. Carbohydr Res 1994 0.81
61 Endodontic pathogens in periodontal disease augmentation. J Clin Periodontol 1995 0.81
62 The Guillain-Barré syndrome as a complication of the postperfusion syndrome. Am Heart J 1972 0.80
63 Properties of a rat monoclonal antibody reactive with both the mannan of Candida species and the O-antigen 6,7 polysaccharide of serogroup C1 salmonellae. Infect Immun 1991 0.80
64 Identification of Bacteroides fragilisby a modified immuno polymerase chain reaction (mIPCR), using a specific monoclonal antibody. Anaerobe 1998 0.80
65 Structure determination of the O-antigenic polysaccharide from the enterotoxigenic Escherichia coli (ETEC) O101. Carbohydr Res 1997 0.80
66 The role of immunoglobulins in amniotic fluid growth inhibition of Bacteroides fragilis, herpes simplex, coxsackie B 5 and cytomegalovirus. Med Microbiol Immunol 1983 0.80
67 Structural studies of the enteroinvasive Escherichia coli (EIEC) O28 O-antigenic polysaccharide. Carbohydr Res 1996 0.80
68 Cross-reactivity between the mannan of Candida species, Klebsiella K24 polysaccharide and Salmonella C1 and E O-antigens is mediated by a terminal non-reducing beta-mannosyl residue. Eur J Biochem 1994 0.80
69 Structural analysis of the O-antigen polysaccharide from the Shiga toxin-producing Escherichia coli O172. Eur J Biochem 2001 0.80
70 Serum antibody response to Bacteroides fragilis in experimental sinusitis. Infection 1992 0.80
71 Structural elucidation of the O-antigenic polysaccharide from Escherichia coli O44:H18. Eur J Biochem 1995 0.80
72 Structural studies utilizing 13C-enrichment of the O-antigen polysaccharide from the enterotoxigenic Escherichia coli O159 cross-reacting with Shigella dysenteriae type 4. Eur J Biochem 1999 0.80
73 Characterization of the common immunodominant antigenic determinant in the lipopolysaccharide of Bacteroides fragilis by a monoclonal antibody. Scand J Immunol 1987 0.79
74 More on the structure of Vibrio cholerae O22 lipopolysaccharide. Carbohydr Res 1998 0.79
75 Structural determination of the O-antigenic polysaccharide from the enterotoxigenic Escherichia coli O147. Eur J Biochem 1998 0.79
76 Identification of Bacteroides fragilis by co-agglutination, using a specific monoclonal antibody. Anaerobe 1997 0.79
77 Structural studies of the O-specific polysaccharide of Vibrio cholerae O8 using solvolysis with triflic acid. Carbohydr Res 2001 0.79
78 Computed tomography of lumbar apophyseal joint lipoma: report of three cases. Neuroradiology 1989 0.79
79 Structure determination of the O-antigenic polysaccharide from the enteroinvasive Escherichia coli O136. Eur J Biochem 1999 0.79
80 Capsular polysaccharides and lipopolysaccharides from two strains of Bacteroides fragilis. Rev Infect Dis 1984 0.79
81 Structural studies of the enterotoxigenic Escherichia coli (ETEC) O153 O-antigenic polysaccharide. Carbohydr Res 1994 0.78
82 Structural analysis of the O-antigenic polysaccharide from Vibrio mimicus N-1990. Eur J Biochem 1998 0.78
83 Comparative effects of the immediate and the extended release formulations of ciprofloxacin on normal human intestinal microflora. J Chemother 2011 0.78
84 Structural studies of the O-antigen polysaccharide from the enteroinvasive Escherichia coli O164 cross-reacting with Shigella dysenteriae type 3. Eur J Biochem 1999 0.78
85 Antibiotic resistance patterns in gram-negative and gram-positive bacteria causing septicemia in newborns in León, Nicaragua: correlation with environmental samples. J Chemother 2010 0.78
86 Structural elucidation of the O-antigen lipopolysaccharide from two strains of Plesiomonas shigelloides that share a type-specific antigen with Shigella flexneri 6, and the common group 1 antigen with Shigella flexneri spp and Shigella dysenteriae 1. Eur J Biochem 1995 0.78
87 Complement activation by Proteus mirabilis negatively charged lipopolysaccharides. J Endotoxin Res 2000 0.78
88 Structural studies of the O-polysaccharide from the Escherichia coli O77 lipopolysaccharide. Carbohydr Res 2001 0.77
89 Low concentrations of immunoglobulin G antibodies to Salmonella serogroup C in C2 deficiency: suggestion of a mannan-binding lectin pathway-dependent mechanism. Scand J Immunol 1999 0.77
90 New attachment in monkeys with experimental periodontitis with and without removal of the cementum. J Clin Periodontol 1987 0.77
91 Structural analysis of the O-antigenic polysaccharide from the enteropathogenic Escherichia coli O142. Eur J Biochem 1997 0.77
92 Structure of the O-specific polysaccharide of an Aeromonas trota strain cross-reactive with Vibrio cholerae O139 Bengal. Eur J Biochem 1996 0.77
93 Structure of the O-antigen of Vibrio cholerae O155 that shares a putative D-galactose 4,6-cyclophosphate-associated epitope with V. cholerae O139 Bengal. Eur J Biochem 1998 0.77
94 CD14-dependent activation of human endothelial cells by Bacteroides fragilis outer membrane. J Surg Res 1998 0.76
95 Prostanoid DP receptor (PTGDR) variants in mothers with post-coital associated preterm births: preliminary observations. J Perinatol 2009 0.76
96 Structural studies of the O-antigen polysaccharide from the enteroinvasive Escherichia coli O173. Carbohydr Res 1999 0.76
97 Structure of the O-specific polysaccharide of Vibrio cholerae O9 containing 2-acetamido-2-deoxy-D-galacturonic acid. Carbohydr Res 2001 0.76
98 Structure determination of the O-antigen polysaccharide from the enteroinvasive Escherichia coli (EIEC) O143 by component analysis and NMR spectroscopy. Carbohydr Res 1996 0.76
99 Prostaglandin regulation of reproductive behaviors in female Xenopus laevis: sources and target sites. Adv Prostaglandin Thromboxane Leukot Res 1987 0.75
100 The dental student as a technician: preclinical and clinical laboratory programs in fixed prosthodontics. J Prosthodont 2001 0.75
101 Penicillin at birth can help prevent early-onset group B streptococcal disease. Pediatrics 1997 0.75
102 [The mind and rheumatism. Report on the symposium "Psychosomatic pain syndrome of the locomotor apparatus" at the Rheumatologic clinic, University of Basle, May 10 and 11, 1974]. Z Rheumatol 1975 0.75
103 Structural determination of the O-antigenic polysaccharide from Escherichia coli O141. Eur J Biochem 1998 0.75
104 Structural studies of the O-antigenic polysaccharides of Escherichia coli O3 and the enteroaggregative Escherichia coli strain 17-2. Eur J Biochem 1994 0.75
105 Encapsulation and protection against phagocytosis by Bacteroides fragilis. Scand J Infect Dis Suppl 1985 0.75
106 [Psychotherapeutic possibilities (especially from the viewpoint of the non-psychiatrist)]. Verh Dtsch Ges Rheumatol 1978 0.75
107 Structural studies of the O-antigen polysaccharide from Escherichia coli O138. Eur J Biochem 1997 0.75
108 Structure elucidation of the O-antigenic polysaccharide from the enteroaggregative Escherichia coli strain 62D1. Eur J Biochem 1999 0.75
109 Predoctoral fixed prosthodontics curriculum survey. J Prosthodont 1998 0.75
110 Structural elucidation of the O-antigenic polysaccharides from Escherichia coli O21 and the enteroaggregative Escherichia coli strain 105. Eur J Biochem 1999 0.75
111 [Contribution to the psychosomatic aspects of progressive chronic polarthritis]. Ther Umsch 1967 0.75
112 Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua. Rev Esp Quimioter 1999 0.75
113 Intravascular and intracardiac ultrasound imaging: current research and future directions. Echocardiography 1990 0.75
114 Intravascular ultrasound assessment of arterial dissection, intimal flaps, and intraarterial thrombi. Am J Card Imaging 1991 0.75
115 [Psychosomatic aspects of soft tissue rheumatism--therapeutic consequences in health resorts and practice]. Z Rheumaforsch 1972 0.75
116 [Limitations in the psychosomatic analysis of backache]. Med Welt 1977 0.75
117 [Psychosomatic aspects of extra-articular rheumatism]. Rev Rhum Mal Osteoartic 1976 0.75
118 [Mental condition of rheumatic patients]. Rev Med Suisse Romande 1969 0.75
119 Endodontic pathogens: propagation of infection through patent dentinal tubules in traumatized monkey teeth. Endod Dent Traumatol 1995 0.75
120 [Psychorheumatology - a new dimension in approaching back and joint diseases]. Med Klin Prax 1982 0.75
121 Phenytoin induces interleukin-1 production in vitro. Life Sci 1989 0.75
122 [Some psychosomatic thoughts in rheumatologic practice]. Rev Med Suisse Romande 1974 0.75
123 [Contribution to the psychosomatics of backache]. Praxis 1967 0.75
124 Structural analysis of the O-antigenic polysaccharide from Vibrio cholerae O10. Eur J Biochem 1997 0.75
125 Structural determination of the O-antigenic polysaccharide from Escherichia coli O35 and cross-reactivity to Salmonella arizonae O62. Eur J Biochem 1998 0.75
126 A multidisciplinary process to improve the efficiency of cardiac operating rooms. J Cardiothorac Vasc Anesth 1999 0.75
127 Structural analysis of the O-antigenic polysaccharide from the enteropathogenic Escherichia coli O125. Eur J Biochem 1996 0.75
128 Secondary syphilis revealed by rheumatic complaints. J Rheumatol 1977 0.75
129 [Some psychosomatic reflexions of epicondylitis (author's transl)]. Ther Umsch 1977 0.75